UBS Group’s Cocrystal Pharma COCP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.7K Buy
21,915
+5,109
+30% +$7.61K ﹤0.01% 6798
2025
Q1
$23.9K Buy
16,806
+10,676
+174% +$15.2K ﹤0.01% 6807
2024
Q4
$12.4K Buy
6,130
+5,220
+574% +$10.5K ﹤0.01% 6960
2024
Q3
$1.6K Buy
+910
New +$1.6K ﹤0.01% 7381
2024
Q2
Sell
-20,258
Closed -$28.4K 8385
2024
Q1
$28.4K Buy
20,258
+20,091
+12,031% +$28.1K ﹤0.01% 5594
2023
Q4
$288 Buy
+167
New +$288 ﹤0.01% 7530
2023
Q3
Sell
-276
Closed -$660 8338
2023
Q2
$660 Sell
276
-1,716
-86% -$4.1K ﹤0.01% 7062
2023
Q1
$3.96K Sell
1,992
-3,023
-60% -$6.02K ﹤0.01% 7150
2022
Q4
$9.78K Buy
5,015
+4,550
+978% +$8.87K ﹤0.01% 7417
2022
Q3
$2K Buy
465
+348
+297% +$1.5K ﹤0.01% 8594
2022
Q2
$1K Sell
117
-1,398
-92% -$11.9K ﹤0.01% 8792
2022
Q1
$10K Sell
1,515
-1,424
-48% -$9.4K ﹤0.01% 7346
2021
Q4
$23K Buy
2,939
+1,939
+194% +$15.2K ﹤0.01% 6558
2021
Q3
$13K Buy
1,000
+149
+18% +$1.94K ﹤0.01% 6516
2021
Q2
$13K Buy
851
+344
+68% +$5.26K ﹤0.01% 6672
2021
Q1
$8K Buy
+507
New +$8K ﹤0.01% 7045
2020
Q4
Sell
-29
Closed 7373
2020
Q3
$0 Sell
29
-1,416
-98% ﹤0.01% 7115
2020
Q2
$26K Buy
1,445
+512
+55% +$9.21K ﹤0.01% 5525
2020
Q1
$8K Buy
933
+925
+11,563% +$7.93K ﹤0.01% 6153
2019
Q4
$0 Buy
+8
New ﹤0.01% 7029
2019
Q3
Sell
-32
Closed -$1K 7013
2019
Q2
$1K Sell
32
-126
-80% -$3.94K ﹤0.01% 6823
2019
Q1
$5K Buy
+158
New +$5K ﹤0.01% 6314
2018
Q4
Sell
-344
Closed -$10K 7079
2018
Q3
$10K Buy
+344
New +$10K ﹤0.01% 6236
2018
Q2
Sell
-217
Closed -$15K 7029
2018
Q1
$15K Buy
+217
New +$15K ﹤0.01% 5730